SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Pluri Inc.
Date: Sept. 22, 2025 · CIK: 0001158780 · Accession: 0000000000-25-010320

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290338

Date
September 22, 2025
Author
Division of
Form
UPLOAD
Company
Pluri Inc.

Letter

Re: Pluri Inc. Registration Statement on Form S-3 Filed September 17, 2025 File No. 333-290338 Dear Yaky Yanay:

September 22, 2025

Yaky Yanay Chief Executive Officer Pluri Inc. MATAM Advanced Technology Park, Building No. 5, Haifa, Israel 3508409

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tim Buchmiller at 202-551-3635 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Howard E. Berkenblit, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 September 22, 2025

Yaky Yanay
Chief Executive Officer
Pluri Inc.
MATAM Advanced Technology Park,
Building No. 5, Haifa, Israel 3508409

 Re: Pluri Inc.
 Registration Statement on Form S-3
 Filed September 17, 2025
 File No. 333-290338
Dear Yaky Yanay:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Tim Buchmiller at 202-551-3635 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Howard E. Berkenblit, Esq.
</TEXT>
</DOCUMENT>